| scholarly article | Q13442814 |
| P2093 | author name string | J. M. Sturgess | |
| D. G. Fagan | |||
| J. R. Imrie | |||
| P2860 | cites work | Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases | Q34426002 |
| Intralumenal intestinal obstruction | Q40001638 | ||
| A review of 164 children with meconium ileus seen at the Children's Hospital Medical Center, Boston | Q40071176 | ||
| The pancreas in cystic fibrosis: chemical composition and comparative morphology | Q67760192 | ||
| Cystic fibrosis of the pancreas. Morphologic findings in infants with and without diagnostic pancreatic lesions | Q69558473 | ||
| THE INTESTINAL LESIONS IN CYSTIC FIBROSIS OF THE PANCREAS | Q76555898 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| cystic fibrosis | Q178194 | ||
| P304 | page(s) | 697-708 | |
| P577 | publication date | 1979-06-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants | |
| P478 | volume | 95 |
| Q37624228 | A novel gene delivery method transduces porcine pancreatic duct epithelial cells. |
| Q55172112 | Abdominal pain in cystic fibrosis. |
| Q36499679 | Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets |
| Q35574197 | An activated immune and inflammatory response targets the pancreas of newborn pigs with cystic fibrosis |
| Q35178642 | Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology. |
| Q30538611 | Cftr controls lumen expansion and function of Kupffer's vesicle in zebrafish |
| Q35097413 | Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model |
| Q72569721 | Chronic alcoholism and hypertension |
| Q55376866 | Cystic Fibrosis-Related Diabetes. |
| Q39690281 | Cystic fibrosis--a gastroenterological cornucopia |
| Q37470271 | Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. |
| Q42172793 | Development of a porcine model of cystic fibrosis. |
| Q36944556 | Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs |
| Q33646755 | Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study |
| Q52874114 | Gastrointestinal complications in cystic fibrosis. |
| Q55386161 | Gastrointestinal tract and nutrition in cystic fibrosis: pathophysiology. |
| Q35136628 | Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass. |
| Q91825728 | Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis |
| Q35595921 | Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas |
| Q24186571 | Omega-3 fatty acids for cystic fibrosis |
| Q40485071 | Ontogeny of human pancreatic exocrine function |
| Q36131548 | Pancreatic damage in fetal and newborn cystic fibrosis pigs involves the activation of inflammatory and remodeling pathways |
| Q36424575 | Pancreatic pathophysiology in cystic fibrosis |
| Q33703755 | Pathology of gastrointestinal organs in a porcine model of cystic fibrosis |
| Q69503720 | Pathophysiology of the exocrine pancreas in cystic fibrosis |
| Q41961145 | Quantitative evaluation of the development of tracheal submucosal glands in infants with cystic fibrosis and control infants |
| Q52878106 | Rationale of modern dietary recommendations in cystic fibrosis. |
| Q40069404 | Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. |
| Q47154527 | Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes |
| Q72569725 | Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin |
| Q35597003 | Value of genetic testing in the management of pancreatitis |
| Q35934114 | Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis. |
Search more.